百川股份(002455.SZ)子公司正異丁醛項目取得環評、安評批覆
格隆匯9月27日丨百川股份(002455.SZ)公佈,近日,寧夏百川科技有限公司取得了寧夏回族自治區寧東能源化工基地管理委員會環境保護局出具的《寧東管(環)[2020]77號》批覆和寧夏回族自治區寧東能源化工基地管理委員會安全生產監督管理局出具的《寧東安監危化項目安條審字[2020]8號》批覆。
寧夏百川科技有限公司實施的正異丁醛項目符合公司未來發展戰略規劃,可以充分利用中西部資源優勢,豐富產品種類,延伸產業鏈,提高產業附加值,可以為寧夏百川科技有限公司“新戊二醇及三羥甲基丙烷項目”提供原料供給,有利於提高公司在行業中的地位,提升公司的市場競爭力,對公司未來的發展將產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.